CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Watson W. Mark Director | Grant or award | +39,400 | 173,525 | ||
| 2026-07-16 | Watson W. Mark Director | Grant or award · Stock Options (right to buy) | +78,700 | 78,700 | ||
| 2026-05-22 | Watson W. Mark Director | Purchase | +10,000 | $0.65 | $7K | 134,125 |
| 2025-11-17 | Watson W. Mark Director | Purchase | +15,000 | $0.41 | $6K | 119,125 |
| 2025-11-17 | Watson W. Mark Director | Purchase | +5,000 | $0.41 | $2K | 124,125 |
| 2025-07-29 | Watson W. Mark Director | Purchase | +10,000 | $0.41 | $4K | 104,125 |
| 2025-06-13 | Watson W. Mark Director | Grant or award | +16,000 | 94,125 | ||
| 2025-06-13 | Watson W. Mark Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2024-06-18 | Watson W. Mark Director | Purchase | +20,000 | $0.68 | $14K | 78,125 |
| 2024-06-11 | Watson W. Mark Director | Grant or award | +16,000 | 58,125 | ||
| 2024-06-11 | Watson W. Mark Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2023-06-26 | Watson W. Mark Director | Grant or award | +7,375 | 42,125 | ||
| 2023-06-26 | Watson W. Mark Director | Grant or award · Stock Option (right to buy) | +44,224 | 44,224 | ||
| 2022-12-28 | Watson W. Mark Director | Purchase | +20,000 | $0.76 | $15K | 20,000 |
| 2022-08-04 | Watson W. Mark Director | Grant or award | +14,750 | 14,750 | ||
| 2022-08-04 | Watson W. Mark Director | Grant or award · Stock Option (right to buy) | +88,448 | 88,448 |
Page 1 of 1 · 16 trades